Heavy Metal Interactions with Neuroglia and Gut Microbiota: Implications for Huntington's Disease
- PMID: 38994995
- PMCID: PMC11240758
- DOI: 10.3390/cells13131144
Heavy Metal Interactions with Neuroglia and Gut Microbiota: Implications for Huntington's Disease
Abstract
Huntington's disease (HD) is a rare but progressive and devastating neurodegenerative disease characterized by involuntary movements, cognitive decline, executive dysfunction, and neuropsychiatric conditions such as anxiety and depression. It follows an autosomal dominant inheritance pattern. Thus, a child who has a parent with the mutated huntingtin (mHTT) gene has a 50% chance of developing the disease. Since the HTT protein is involved in many critical cellular processes, including neurogenesis, brain development, energy metabolism, transcriptional regulation, synaptic activity, vesicle trafficking, cell signaling, and autophagy, its aberrant aggregates lead to the disruption of numerous cellular pathways and neurodegeneration. Essential heavy metals are vital at low concentrations; however, at higher concentrations, they can exacerbate HD by disrupting glial-neuronal communication and/or causing dysbiosis (disturbance in the gut microbiota, GM), both of which can lead to neuroinflammation and further neurodegeneration. Here, we discuss in detail the interactions of iron, manganese, and copper with glial-neuron communication and GM and indicate how this knowledge may pave the way for the development of a new generation of disease-modifying therapies in HD.
Keywords: Huntington’s disease; copper; glial cells; gut microbiota; gut–brain axis; heavy metals; iron; manganese; neuroinflammation.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures

Similar articles
-
Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.Elife. 2021 Apr 19;10:e64564. doi: 10.7554/eLife.64564. Elife. 2021. PMID: 33871358 Free PMC article.
-
Microbiota dysbiosis impact on the immune system dysregulation in Huntington's disease (HD).Int Rev Neurobiol. 2025;180:57-94. doi: 10.1016/bs.irn.2025.04.002. Epub 2025 May 2. Int Rev Neurobiol. 2025. PMID: 40414643 Review.
-
The microbiota-gut-brain axis in Huntington's disease: pathogenic mechanisms and therapeutic targets.FEBS J. 2025 Mar;292(6):1282-1315. doi: 10.1111/febs.17102. Epub 2024 Mar 1. FEBS J. 2025. PMID: 38426291 Free PMC article. Review.
-
What the Gut Tells the Brain-Is There a Link between Microbiota and Huntington's Disease?Int J Mol Sci. 2023 Feb 24;24(5):4477. doi: 10.3390/ijms24054477. Int J Mol Sci. 2023. PMID: 36901907 Free PMC article. Review.
-
Gut Microbiota as a Modifier of Huntington's Disease Pathogenesis.J Huntingtons Dis. 2024;13(2):133-147. doi: 10.3233/JHD-240012. J Huntingtons Dis. 2024. PMID: 38728199 Free PMC article. Review.
Cited by
-
Mitochondrial pathways of copper neurotoxicity: focus on mitochondrial dynamics and mitophagy.Front Mol Neurosci. 2024 Dec 5;17:1504802. doi: 10.3389/fnmol.2024.1504802. eCollection 2024. Front Mol Neurosci. 2024. PMID: 39703721 Free PMC article. Review.
-
Neuroinflammation and neurodegeneration in Huntington's disease: genetic hallmarks, role of metals and organophosphates.Neurogenetics. 2025 Jan 17;26(1):21. doi: 10.1007/s10048-025-00801-2. Neurogenetics. 2025. PMID: 39820855 Review.
References
-
- Ajitkumar A., De Jesus O. Huntington Disease. StatPearls Publishing; Treasure Island, FL, USA: 2024. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical